Transferrin Trojan Horses as a Rational Approach for the Biological Delivery of Therapeutic Peptide Domains
Open Access
- 1 August 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (34) , 24066-24073
- https://doi.org/10.1074/jbc.274.34.24066
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Inhibition of HIV-1 Replication by a Tat RNA-Binding Domain Peptide AnalogJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.Journal of Clinical Investigation, 1997
- A femtomolar-acting neuroprotective peptide.Journal of Clinical Investigation, 1996
- HIV-1 Membrane Fusion Mechanism: Structural Studies of the Interactions between Biologically-Active Peptides from gp41Biochemistry, 1996
- Intoxication of cultured cells by cholera toxin: evidence for different pathways when bound to ganglioside GM1 or neoganglioproteinsBiochemistry, 1992
- Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expressionSomatic Cell and Molecular Genetics, 1992
- Heterogeneity of the human transferrin receptor and use of anti‐transferrin receptor antibodies to detect tumours in vivoImmunology & Cell Biology, 1987
- Killing of human tumor cells in culture with adriamycin conjugates of human transferrinClinical Immunology and Immunopathology, 1984
- Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells.The Journal of cell biology, 1983
- Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cellsNature, 1981